SCHEMBL1385196

SCHEMBL1385196

O=C(O)Nc1ccc(C(=O)/C=C/c2cc(N3CCOCC3)c3ccccc3n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MOK Q9UQ07 1/20 0.55
NCF1 P14598 2/20 0.49
MAPT P10636 6/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
KDM4E B2RXH2 3/20 0.48
HIF1A Q16665 2/20 0.48
MAOB P27338 1/20 0.47
RAB9A P51151 4/20 0.47
NPC1 O15118 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
PKM P14618 1/20 0.47
PIK3R1 P27986 4/20 0.46
PIK3CA P42336 4/20 0.46
MTOR P42345 4/20 0.46
USP2 O75604 1/20 0.46
ALDH1A1 P00352 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1385200 1.00 MOK (0.55) MOKNCF1MAPTCYP1A2CYP3A4
Thiophene SCHEMBL5496485 0.95 MOK (0.52) MOKNCF1MAPTCYP1A2CYP3A4
Thiophene SCHEMBL5496494 0.95 MOK (0.52) MOKNCF1MAPTCYP1A2CYP3A4
SCHEMBL5090188 0.92 MTOR (0.53) MOKMAPTKDM4EMAOBRAB9A
SCHEMBL5090197 0.92 MTOR (0.53) MOKMAPTKDM4EMAOBRAB9A
SCHEMBL1386140 0.91 MOK (0.54) MOKNCF1MAPTCYP1A2CYP3A4
SCHEMBL1386142 0.91 MOK (0.54) MOKNCF1MAPTCYP1A2CYP3A4
SCHEMBL5096014 0.90 BCHE (0.50) MOKNCF1MAPTKDM4EMEN1
SCHEMBL5096010 0.90 BCHE (0.50) MOKNCF1MAPTKDM4EMEN1
SCHEMBL1381775 0.90 MOK (0.51) MOKNCF1MAPTCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4790704-B2 2011-10-12 JP claimed
EP-1748987-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS Torrent Pharmaceuticals Ltd (IN) 2007-02-07 EP claimed
WO-2005097746-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS TORRENT PHARMACEUTICALS LTD (IN) 2005-10-20 WO claimed
US-20080207608-A1 2-Propene-1-Ones As Hsp 70 Inducers TORRENT PHARMACEUTICALS LTD. (IN) 2008-08-28 US disclosed
EP-1748987-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS Torrent Pharmaceuticals Ltd (IN) 2007-02-07 EP disclosed
WO-2005097746-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS TORRENT PHARMACEUTICALS LTD (IN) 2005-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207608-A1 2-Propene-1-Ones As Hsp 70 Inducers HSPB1, HSF1, HSPE1 MOK 3975/4885NCF1 2333/4885MAPT 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.